*By Alex Heath* Tinder’s business is exploding. The dating app is on track to generate $800 million in revenue this year, its parent company Match Group said this week. That’s double what Tinder brought in for 2017, and with a profit margin greater than 40 percent, the app is set to make roughly $320 million in profit this year. Tinder makes money through its two subscription plans, Tinder Plus and Tinder Gold. The pricing for both plans is variable, depending on where in the world subscribers live and their age. Earlier this year, a California appeals court ruled against Tinder in an age-discrimination lawsuit for charging users older than 30 double what it charges younger subscribers. As Facebook is planning to release its own dating features, Tinder is quickly adding new features. The app aims to appeal to its core millennial audience with a feature for connecting college students that should be available in the coming weeks.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More